Privium Fund Management (UK)’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-114,708
| Closed | -$233K | – | 132 |
|
|
2024
Q2 | $233K | Sell |
114,708
-5,022
| -4% | -$10.2K | 0.09% | 144 |
|
|
2024
Q1 | $496K | Hold |
119,730
| – | – | 0.25% | 60 |
|
|
2023
Q4 | $225K | Hold |
119,730
| – | – | 0.15% | 66 |
|
|
2023
Q3 | $201K | Hold |
119,730
| – | – | 0.16% | 65 |
|
|
2023
Q2 | $272K | Hold |
119,730
| – | – | 0.21% | 57 |
|
|
2023
Q1 | $401K | Hold |
119,730
| – | – | 0.32% | 51 |
|
|
2022
Q4 | $321K | Buy |
119,730
+84,730
| +242% | +$227K | 0.24% | 40 |
|
|
2022
Q3 | $104K | Buy |
+35,000
| New | +$104K | 0.13% | 49 |
|